Your browser doesn't support javascript.
loading
The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults.
Sieswerda, Elske; Bax, Hannelore I; Hoogerwerf, Jacobien J; de Boer, Mark G J; Boermeester, Marja; Bonten, Marc J M; Dekker, Douwe; van Wijk, Roy Gerth; Juffermans, Nicole P; Kuindersma, Marnix; van der Linden, Paul D; Melles, Damian C; Pickkers, Peter; Schouten, Jeroen A; Rebel, Jasper R; van Zanten, Arthur R H; Prins, Jan M; Wiersinga, W Joost.
Affiliation
  • Sieswerda E; Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands. e.sieswerda@umcutrecht.nl.
  • Bax HI; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. e.sieswerda@umcutrecht.nl.
  • Hoogerwerf JJ; Department of Internal Medicine, Section of Infectious Diseases and Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • de Boer MGJ; Department of Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Boermeester M; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Bonten MJM; Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Dekker D; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • van Wijk RG; Department of Internal Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Juffermans NP; Division of Allergology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Kuindersma M; Department of Intensive Care, OLVG Hospital, Amsterdam, The Netherlands.
  • van der Linden PD; Department of Intensive Care, Gelre ziekenhuis Apeldoorn, Apeldoorn, The Netherlands.
  • Melles DC; Department of Clinical Pharmacy, Tergooi Hospital, Hilversum, The Netherlands.
  • Pickkers P; Department of Medical Microbiology and Immunology, Meander Medical Center, Amersfoort, The Netherlands.
  • Schouten JA; Department of Intensive Care Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Rebel JR; Department of Intensive Care Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Zanten ARH; Department of Emergency Medicine, OLVG Hospital, Amsterdam, The Netherlands.
  • Prins JM; Department of Intensive Care Medicine, Ziekenhuis Gelderse Vallei, Ede, The Netherlands.
  • Wiersinga WJ; Division of Infectious Diseases, Department of Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
BMC Infect Dis ; 22(1): 687, 2022 Aug 11.
Article de En | MEDLINE | ID: mdl-35953772
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sepsie / Antibactériens Type d'étude: Guideline / Prognostic_studies Limites: Adult / Humans Pays/Région comme sujet: Europa Langue: En Journal: BMC Infect Dis Sujet du journal: DOENCAS TRANSMISSIVEIS Année: 2022 Type de document: Article Pays d'affiliation: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sepsie / Antibactériens Type d'étude: Guideline / Prognostic_studies Limites: Adult / Humans Pays/Région comme sujet: Europa Langue: En Journal: BMC Infect Dis Sujet du journal: DOENCAS TRANSMISSIVEIS Année: 2022 Type de document: Article Pays d'affiliation: Pays-Bas